{"id":"W4412523022","doi":"10.1016/s1474-4422(25)00174-7","title":"Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study","year":2025,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Roche","keywords":"Medicine; Clinical endpoint; Placebo; Internal medicine; Population; Expanded Disability Status Scale; Adverse effect; Clinical trial; Multiple sclerosis; Clinically isolated syndrome; Phases of clinical research; Surrogate endpoint; Physical therapy; Pathology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003061281,0.00227558,0.004229982,0.0004878418,0.0007319438,0.001249928,0.001132954,0.002909937,0.00589839],"category_scores_gemma":[0.002409351,0.0008124487,0.002558957,0.0003997045,0.001319611,0.001709982,0.0005518313,0.003416133,0.001225558],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008402874,"about_ca_system_score_gemma":0.001231566,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009860562,"about_ca_topic_score_gemma":0.001834313,"domain_scores_codex":[0.9990491,0.0004649712,0.00005616998,0.0001776075,0.00009072999,0.0001613062],"domain_scores_gemma":[0.9987205,0.000299466,0.0002969879,0.000125637,0.000119897,0.0004374204],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9822822,0.003780258,0.0006470535,0.0004952367,0.001033938,0.00004256342,0.00004625356,0.0001339111,0.002355962,0.00007015354,0.000682042,0.008430517],"study_design_scores_gemma":[0.9584913,0.03644737,0.00359169,0.00002812533,0.0004685215,0.00004659468,0.00001557342,0.00014541,0.0002259823,0.00008697796,0.0004349305,0.0000176265],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860644,0.00696299,0.0004606163,0.0006545158,0.000404495,0.002052742,0.001472531,0.00008373177,0.001843913],"genre_scores_gemma":[0.9858996,0.002537675,0.001470464,0.001469181,0.000524205,0.003725212,0.001708884,0.00003370496,0.002630971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00589839,"threshold_uncertainty_score":0.01973206,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1661435849068361,"score_gpt":0.4016988338568246,"score_spread":0.2355552489499884,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}